WordNet

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 薬物アレルギー患者へのアプローチ an approach to the patient with drug allergy
2. 抗マラリア剤：概要 antimalarial drugs an overview
3. 成人における薬物中毒への一般的アプローチ general approach to drug poisoning in adults
4. リウマチ性疾患における免疫抑制剤および疾患修飾剤の使用の概要 overview of the use of immunosuppressive and disease modifying drugs in the rheumatic diseases
5. 処方剤の誤用：疫学、予防、同定、およびマネージメント prescription drug misuse epidemiology prevention identification and management

Synergistic targeting/prodrug strategies for intravesical drug delivery - Lectin-modified PLGA microparticles enhance cytotoxicity of stearoyl gemcitabine by contact-dependent transfer.

Neutsch L, Wirth EM, Spijker S, Pichl C, Kählig H, Gabor F, Wirth M.SourceUniversity of Vienna, Department of Pharmaceutical Technology and Biopharmaceutics, Vienna A 1090, Austria.
Journal of controlled release : official journal of the Controlled Release Society.J Control Release.2013 Apr 12;169(1-2):62-72. doi: 10.1016/j.jconrel.2013.04.004. [Epub ahead of print]
The direct access to the urothelial tissue via intravesical therapy has emerged as a promising means for reducing the high recurrence rate of bladder cancer. However, few advanced delivery concepts have so far been evaluated to overcome critical inherent efficacy limitations imposed by short exposur
PMID 23588390

Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line.

Nishi R, Yamauchi T, Negoro E, Takemura H, Ueda T.SourceDepartment of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Fukui, Japan.
Cancer science.Cancer Sci.2013 Apr;104(4):502-7. doi: 10.1111/cas.12103. Epub 2013 Feb 24.
Cytarabine (ara-C) is the key agent for treating acute myeloid leukemia. After being transported into leukemic cells, ara-C is phosphorylated, by several enzymes including deoxycytidine kinase (dCK), to ara-C triphosphate (ara-CTP), an active metabolite, and then incorporated into DNA, thereby inhib
PMID 23320492

Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcome the cytarabine resistance in HL-60 leukemia cell line.